Kathryn Ball

673 total citations
15 papers, 407 citations indexed

About

Kathryn Ball is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Kathryn Ball has authored 15 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Pharmacology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kathryn Ball's work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Kathryn Ball is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Kathryn Ball collaborates with scholars based in France, United Kingdom and United States. Kathryn Ball's co-authors include François Bouzom, Bernard Walther, Xavier Declèves, Jean‐Michel Scherrmann, Pavan Vajjah, Alex Phipps, Simon J. Dovedi, Arnaud Bruyère, Stéphane Mouly and Yves Panís and has published in prestigious journals such as Analytical Chemistry, Journal of Pharmaceutical Sciences and Molecular Cancer Therapeutics.

In The Last Decade

Kathryn Ball

15 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn Ball France 10 211 96 90 85 62 15 407
Naotoshi Yamamura Japan 11 116 0.5× 72 0.8× 82 0.9× 157 1.8× 22 0.4× 35 479
Clifford DiLea United States 11 140 0.7× 71 0.7× 27 0.3× 119 1.4× 43 0.7× 24 438
William Neway United States 11 203 1.0× 98 1.0× 121 1.3× 264 3.1× 14 0.2× 14 557
Armin Bruelisauer Switzerland 8 136 0.6× 81 0.8× 80 0.9× 120 1.4× 18 0.3× 10 474
Atsushi Ose Japan 10 346 1.6× 129 1.3× 182 2.0× 128 1.5× 13 0.2× 18 601
Soraya Madani United States 6 153 0.7× 291 3.0× 38 0.4× 86 1.0× 32 0.5× 8 534
Tonika Bohnert United States 9 138 0.7× 61 0.6× 21 0.2× 228 2.7× 39 0.6× 9 558
Fabienne Z. Gaugaz Sweden 7 157 0.7× 68 0.7× 63 0.7× 212 2.5× 19 0.3× 13 471
David F. Gebhard United States 8 148 0.7× 63 0.7× 67 0.7× 226 2.7× 16 0.3× 12 544
Junko Ushiki Japan 10 325 1.5× 73 0.8× 162 1.8× 161 1.9× 18 0.3× 14 564

Countries citing papers authored by Kathryn Ball

Since Specialization
Citations

This map shows the geographic impact of Kathryn Ball's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Ball with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Ball more than expected).

Fields of papers citing papers by Kathryn Ball

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Ball. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Ball. The network helps show where Kathryn Ball may publish in the future.

Co-authorship network of co-authors of Kathryn Ball

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Ball. A scholar is included among the top collaborators of Kathryn Ball based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Ball. Kathryn Ball is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Huang, Yue, Jiaqi Yuan, Kathryn Ball, et al.. (2024). Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying Its Stability In Vivo. Analytical Chemistry. 96(42). 16525–16533. 9 indexed citations
2.
Ball, Kathryn, Simon J. Dovedi, Pavan Vajjah, & Alex Phipps. (2023). Strategies for clinical dose optimization of T cell-engaging therapies in oncology. mAbs. 15(1). 2181016–2181016. 41 indexed citations
3.
4.
Gregson, Stephen J., Neki V. Patel, Balakumar Vijayakrishnan, et al.. (2022). Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody–Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine Dimer. Molecular Cancer Therapeutics. 21(9). 1439–1448. 4 indexed citations
5.
Ball, Kathryn, Gerard Bruin, Enrique Escandón, et al.. (2022). Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White Paper. Drug Metabolism and Disposition. 50(6). 858–866. 9 indexed citations
6.
Reddy, Venkatesh Pilla, et al.. (2022). Development of and insights from systems pharmacology models of antibody‐drug conjugates. CPT Pharmacometrics & Systems Pharmacology. 11(8). 967–990. 4 indexed citations
7.
Hénin, Émilie, Kathryn Ball, Julien Ogier, et al.. (2019). Prediction of Human Nonlinear Pharmacokinetics of a New Bcl-2 Inhibitor Using PBPK Modeling and Interspecies Extrapolation Strategy. Drug Metabolism and Disposition. 47(6). 648–656. 8 indexed citations
8.
Ball, Kathryn, et al.. (2017). Prediction of renal transporter-mediated drug-drug interactions for a drug which is an OAT substrate and inhibitor using PBPK modelling. European Journal of Pharmaceutical Sciences. 106. 122–132. 23 indexed citations
9.
Ball, Kathryn, François Bouzom, Jean‐Michel Scherrmann, Bernard Walther, & Xavier Declèves. (2014). Comparing translational population‐PBPK modelling of brain microdialysis with bottom‐up prediction of brain‐to‐plasma distribution in rat and human. Biopharmaceutics & Drug Disposition. 35(8). 485–499. 15 indexed citations
10.
Ball, Kathryn, François Bouzom, Jean‐Michel Scherrmann, Bernard Walther, & Xavier Declèves. (2014). A Physiologically Based Modeling Strategy during Preclinical CNS Drug Development. Molecular Pharmaceutics. 11(3). 836–848. 20 indexed citations
11.
Ball, Kathryn, François Bouzom, Jean‐Michel Scherrmann, Bernard Walther, & Xavier Declèves. (2013). Physiologically Based Pharmacokinetic Modelling of Drug Penetration Across the Blood–Brain Barrier—Towards a Mechanistic IVIVE-Based Approach. The AAPS Journal. 15(4). 913–932. 33 indexed citations
12.
Ball, Kathryn, François Bouzom, Jean‐Michel Scherrmann, Bernard Walther, & Xavier Declèves. (2012). Development of a Physiologically Based Pharmacokinetic Model for the Rat Central Nervous System and Determination of an In Vitro–In Vivo Scaling Methodology for the Blood–Brain Barrier Permeability of Two Transporter Substrates, Morphine and Oxycodone. Journal of Pharmaceutical Sciences. 101(11). 4277–4292. 44 indexed citations
13.
Bouzom, François, et al.. (2012). Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?. Biopharmaceutics & Drug Disposition. 33(2). 55–71. 70 indexed citations
14.
Bruyère, Arnaud, Xavier Declèves, François Bouzom, et al.. (2010). Effect of Variations in the Amounts of P-Glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the Human Small Intestine on PBPK Models for Predicting Intestinal First Pass. Molecular Pharmaceutics. 7(5). 1596–1607. 74 indexed citations
15.
Ball, Kathryn. (1981). Selected Methods in Cellular Immunology. Immunology. 42(3). 492. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naotoshi Yamamura Breakdown of academic impact, for papers by Clifford DiLea Breakdown of academic impact, for papers by William Neway Breakdown of academic impact, for papers by Armin Bruelisauer Breakdown of academic impact, for papers by Atsushi Ose Breakdown of academic impact, for papers by Soraya Madani Breakdown of academic impact, for papers by Tonika Bohnert Breakdown of academic impact, for papers by Fabienne Z. Gaugaz Breakdown of academic impact, for papers by David F. Gebhard Breakdown of academic impact, for papers by Junko Ushiki
Rankless by CCL
2026